Improving care for heart surgery patients through digital services

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of digital services on perioperative care for patients undergoing cardiac surgery. Participants will be randomized into three groups: one receiving standard care, another receiving intensified education through traditional methods, and a third utilizing a mobile app for enhanced communication and rehabilitation. The goal is to establish individualized rehabilitation plans and improve patient-reported outcomes through better information exchange and support. By integrating digital tools, the study aims to enhance the quality of life and reduce postoperative complications.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient is capable of giving consent;
* planned, elective cardiac surgery (coronary bypass surgery and heart valve surgery incl. combination surgery). The planned surgery can be performed with or without a heart-lung machine.
* Minimally invasive procedures may also be explicitly included in the study.

Exclusion Criteria:

* Emergency care;
* congenital heart defects;
* age less than 18 years;
* patient unable to give consent;
* patient unable to perform simple physical training;
* high-risk surgery with a calculated Euroscore II of more than 8%.

Where it's running

• Medical School Hanover
  Hanover, Lower Saxony, Germany Recruiting

Study contacts

• Study coordinator: Bastian Schmack, PD
• Email: Schmack.bastian@mh-hannover.de
• Phone: 0511-532-3452

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using Apple Watch data to predict heart failure outcomes

  This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.

  Recruiting University Medical Center Goettingen · Goettigen, Lower Saxony · NCT06819618

• Comparing Aortix Device to Diuretics for Acute Heart Failure

  This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.

  Recruiting at 33 sites Procyrion · Phoenix, Arizona and 49 other locations · NCT05677100

• Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS

  Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.

  Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital · Beijing · NCT07912086

• Tailored digital support to cut sedentary time in long-term cardiac rehab

  In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.

  Recruiting University of Lisbon · Lisbon, Lisbon District · NCT07910812

• NT-proBNP–guided heart failure screening for people 65+ in rural China

  This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.

  Recruiting Jiangsu Taizhou People's Hospital · Nanjing · NCT07885488

• Voice-based detection of heart failure deterioration using Noah Labs Vox

  This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.

  Recruiting Noah Labs · Boston, Massachusetts · NCT07870395

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.